2005Acta Academiae Medicinae JiangxiRequires access

Treatment of Advanced Pancreatic Cancer with Combination of Gemcitabine and Oxaliplatin

Hong Lian

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy and safety of gemcitabine and oxaliplatin in the patients with advanced pancreatic cancer.Methods Twenty-one patients were enrolled.The treatment consisted of gemcitabine 1000 mg/m~2(30 minute infusion)on day 1 and 8 and oxaliplatin 130 mg/m~2(2 hour infusion)on day 1 every 3~4 weeks.Results Sixteen patients were evaluable.Complete response was observed in 0 patient.Partial responses were observed in 2 patients,stable disease in 8 and progress disease in 6.The overall response was 12.5%.The Treatment was well tolerated.Conclusion Gemcitabine and oxaliplatin showed encouraging activity in the patients with advanced pancreatic cancer.

About this research paper

What this paper is about

Objective To evaluate the efficacy and safety of gemcitabine and oxaliplatin in the patients with advanced pancreatic cancer.Methods Twenty-one patients were enrolled.The treatment consisted of gemcitabine 1000 mg/m~2(30 minute infusion)on day 1 and 8 and oxaliplatin 130 mg/m~2(2 hour infusion)on day 1 every 3~4 weeks.Results Sixteen patients were evaluable.Complete response was observed in 0 patient.Partial responses were observed in 2 patients,stable disease in 8 and progress disease in 6.The overall response was 12.5%.The Treatment was well tolerated.Conclusion Gemcitabine and oxaliplatin showed encouraging activity in the patients with advanced pancreatic cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy and safety of gemcitabine and oxaliplatin in the patients with advanced pancreatic cancer.Methods Twenty-one patients were enrolled.The treatment consisted of gemcitabine 1000 mg/m~2(30 minute infusion)on day 1 and 8 and oxaliplatin 130 mg/m~2(2 hour infusion)on day 1 every 3~4 weeks.Results Sixteen patients were evaluable.Complete response was observed in 0 patient.Partial responses were observed in 2 patients,stable disease in 8 and progress disease in 6.The overall response was 12.5%.The Treatment was well tolerated.Conclusion Gemcitabine and oxaliplatin showed encouraging activity in the patients with advanced pancreatic cancer.

Key concepts: Gemcitabine, Oxaliplatin, Medicine, Pancreatic cancer, Internal medicine, Oncology, Progressive disease, Chemotherapy

Back to paper searchBrowse research topicsOriginal source
Treatment of Advanced Pancreatic Cancer with Combination of Gemcitabine and Oxaliplatin — Research Paper | ScholarLens